Narbasa, Alicia .

HRN: 28-68-54  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/10/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/10/2026
03/16/2026
IV
4.5
Q8
Cellulitis
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft TissueProphylaxis    Compliance to guidelines: Compliant To Guidelines